I think the share price has the potential to really move once BTI has a first time in human event. That could easily happen in 2021 with Chiesi, Prothena or even with the un-named pharma. I believe the un-named pharma might have to be named at that point as first time in human for BTI would be a material event. I think new deals will also drive sp but perhaps not the same way as first time in human for BTI.